Evaluate the Safety, Tolerability and Immunogenicity Study of GLS-5300 in Healthy Volunteers
Clinical trial NCT03721718 · COMPLETED
Trial details
- NCT number
- NCT03721718
- Sponsor
- GeneOne Life Science, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-28
- Primary completion
- 2019-05-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.